Charles Gauthier

Charles Gauthier is a seasoned professional in program and project management within the pharmaceutical and biotechnology sectors. Currently serving as a Senior Program Director at AbbVie since August 2024, Gauthier previously held the position of Sr. Director of Portfolio and Program Management at Cerevel Therapeutics until its acquisition by AbbVie. Gauthier has extensive experience managing pivotal programs, including lead development candidates for Parkinson’s Disease at Cerevel and mirvetuximab soravtansine at ImmunoGen, where responsibilities encompassed strategic planning, operational execution, and budget management. Gauthier's career includes roles at Novartis and Millennium Pharmaceuticals, enriching expertise in research project management and operational oversight. Gauthier holds an MBA in Business Administration from Suffolk University, a Project Management Certificate from Boston University, and a BS in Biology from Worcester State University.